Raed M Maklad

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Community Acquired Pneumonia

Preterm Infants

Methicillin Resistant Staphylococcus Aureus

Liquid Chromatography Tandem Mass Spectrometry

Top Venues

Drug development research

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Islam S Marae, Raed M Maklad, Safia Samir, Etify A Bakhite, Walid Sharmoukh
Thieno[2,3-c]isoquinolines: A novel chemotype of antiproliferative agents inducing cellular apoptosis while targeting the G2/M phase and Tubulin. Drug development research (2023)
Tarfah Al-Warhi, Hadia Almahli, Raed M Maklad, Zainab M Elsayed, Mahmoud A El Hassab, Ohoud J Alotaibi, Nada Aljaeed, Rezk R Ayyad, Hazem A Ghabour, Wagdy M Eldehna, Mohamed Kandeel El-Ashrey
1-Benzyl-5-bromo-3-hydrazonoindolin-2-ones as Novel Anticancer Agents: Synthesis, Biological Evaluation and Molecular Modeling Insights. Molecules (Basel, Switzerland) 28 (7) (2023)
Tarfah Al-Warhi, Diaaeldin M Elimam, Zainab M Elsayed, Marwa M Abdel-Aziz, Raed M Maklad, Ahmed Ali Al-Karmalawy, Kamyar Afarinkia, Mohammed A S Abourehab, Hatem A Abdel-Aziz, Wagdy M Eldehna
Development of novel isatin thiazolyl-pyrazoline hybrids as promising antimicrobials in MDR pathogens. RSC advances 12 (48) (2022)